US$6.8M (A$9.8M) in cash with loans of US$2.8M (A$4.0M), so a...

US$6.8M (A$9.8M) in cash with loans of US$2.8M (A$4.0M), so a net cash position of US$4.0M (A$5.8M).

So although VTI are burning cash they are valued at 1.2x their cash position, understand this is dwindling.... I cannot help but feel at the current market pricing they are a takeover target.

If you wanted a piece of this future myopia pie, a suitor could get this for next to nothing, for a business that although is loss making, has an established inventory and logistics process with sales in multiple geographies, and healthy clinical trials....

An interesting time for VTI, and very risky potential spec investment... Time will tell